Bring the future of AI-driven R&D to Pharma
Pharma companies are seeking cutting edge platforms to accelerate drug discovery and development.
Most firms lack a deep, domain-specific AI solution tailored for biomedical R&D.
Partner with Owkin to unlock high-value agentic decision making across drug discovery, translational research, and clinical development for your clients.
Bring K Pro directly into your pharma engagements
Built to accelerate every step of the drug discovery and development pipeline
Rank therapeutic targets and gene candidates using statistical evidence from TCGA and MOSAIC datasets.
Evaluate target tractability, safety profiles, and therapeutic potential using curated databases.
Identify distinct populations based on multi-omics profiles and clinical outcomes.
Test biomarkers and hypotheses across bulk RNA-seq, single-cell, spatial, and clinical data.
Publication-ready reports for gene/target assessment, biomarker prioritization, and patent landscape analysis.
Integrate genomic,transcriptomic, and immune data to identify therapeutic opportunities and predict treatment response.